These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20633180)

  • 1. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement.
    Sheean G; Lannin NA; Turner-Stokes L; Rawicki B; Snow BJ;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():74-93. PubMed ID: 20633180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients.
    Rousseaux M; Kozlowski O; Froger J
    J Neurol; 2002 Jan; 249(1):76-84. PubMed ID: 11954872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin assessment, intervention and aftercare for cervical dystonia and other causes of hypertonia of the neck: international consensus statement.
    Novak I; Campbell L; Boyce M; Fung VS;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():94-108. PubMed ID: 20633181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: international consensus statement.
    Fehlings D; Novak I; Berweck S; Hoare B; Stott NS; Russo RN;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():38-56. PubMed ID: 20633178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement.
    Olver J; Esquenazi A; Fung VS; Singer BJ; Ward AB;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():57-73. PubMed ID: 20633179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
    J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments--introduction.
    Esquenazi A; Novak I; Sheean G; Singer BJ; Ward AB
    Eur J Neurol; 2010 Aug; 17 Suppl 2():1-8. PubMed ID: 20633176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
    Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
    Lam K; Lau KK; So KK; Tam CK; Wu YM; Cheung G; Liang KS; Yeung KM; Lam KY; Yui S; Leung C
    J Am Med Dir Assoc; 2012 Jun; 13(5):477-84. PubMed ID: 22521630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin assessment, intervention and aftercare for paediatric and adult niche indications including pain: international consensus statement.
    Rawicki B; Sheean G; Fung VS; Goldsmith S; Morgan C; Novak I;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():122-34. PubMed ID: 20633183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of three-dimensional kinematic analysis following upper limb botulinum toxin A for children with hemiplegia.
    Mackey AH; Miller F; Walt SE; Waugh MC; Stott NS
    Eur J Neurol; 2008 Nov; 15(11):1191-8. PubMed ID: 18727674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over 25 Years of Pediatric Botulinum Toxin Treatments: What Have We Learned from Injection Techniques, Doses, Dilutions, and Recovery of Repeated Injections?
    Sätilä H
    Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32640636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robot-mediated and clinical scales evaluation after upper limb botulinum toxin type A injection in children with hemiplegia.
    Frascarelli F; Masia L; Di Rosa G; Petrarca M; Cappa P; Castelli E
    J Rehabil Med; 2009 Nov; 41(12):988-94. PubMed ID: 19841830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy.
    Intiso D; Simone V; Di Rienzo F; Iarossi A; Pazienza L; Santamato A; Maruzzi G; Basciani M
    NeuroRehabilitation; 2014; 34(3):515-22. PubMed ID: 24473245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin injections for pediatric patients with hereditary spastic paraparesis.
    Geva-Dayan K; Domenievitz D; Zahalka R; Fattal-Valevski A
    J Child Neurol; 2010 Aug; 25(8):969-75. PubMed ID: 20406997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poststroke hypertonicity: upper limb assessment and treatment.
    Marciniak C
    Top Stroke Rehabil; 2011; 18(3):179-94. PubMed ID: 21642056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.